Fred Hutch trial halted after promising HIV vaccine failed to show efficacy
On Feb. 4, 2020, the Fred Hutchinson Cancer Research Center announced that a promising HIV vaccine trial was…
Xencor and Gilead entered license agreement for use of XmAb antibody technologies in investigational agents for HIV
On Jan. 8, 2020, Xencor announced a technology license agreement in which Gilead Sciences will access Xencor’s Xtend…
PATH announced Nikolaj Gilbert as President and CEO
On Dec. 4, 2019, PATH announced that its Board of Directors had unanimously chosen global development leader Nikolaj…
Abbott announced discovery of a new strain of HIV
On Nov. 6, 2019, Abbott announced that a team of its scientists identified a new subtype of the…
Chembio Diagnostics received WHO prequalification approval for HIV Self-Test
On Nov. 4, 2019, Chembio Diagnostics announced its SURE CHECK HIV Self-Test has received World Health Organization (WHO)…
Biotechnology | CDC | Disease | HIV | Non-Profit Research | Pharmaceutical | Vaccine
CDC published ACIP recommendations for use of meningococcal conjugate vaccines in HIV-infected persons
On Nov. 4, 2016, the U.S. Centers for Disease Control and Prevention’s (CDC) Immunization Practices Advisory Committee (ACIP)…
HIV research cleared name of ‘Patient Zero,’ Gaetan Dugas
On Oct, 26, 2016, a team of researchers at the University of Arizona and University of Cambridge in…
UNMC researchers probed aging, HIV-infected brain with $22 million NIH grant
On Apr. 4, 2016, UNMC researchers, Tony Wilson, Ph.D., and Susan Swindells, M.B.B.S., working with a $2.2 million,…
The New England Primate Research Center closed its doors
On May 31, 2015, the New England Primate Research Center (NEPRC) closed its doors. During its five decades…
OHSU scientist awarded $25 million grant to further HIV vaccine research
On Sept. 3, 2014, Oregon Health & Science University (OHSU) announced it had been awarded a $25 million…
Myron Cohen received the North Carolina Award for Science
On Oct. 22, 2013 Myron Cohen received the North Carolina Award for Science. Dr. Cohen is a University…
HIV/AIDS researcher David Ho won NIDA’s 2011 Avant-Garde Award
On Aug. 12, 2011, the National Institute on Drug Abuse (NIDA), part of NIH, announced that Dr. David…
Biotechnology | CDC | Disease | HIV | Infectious Disease
The CDC marked the first AIDS cases reported
On Jun. 11, 2011, the U.S. Centers for Disease Control and Prevention (CDC) marked the 30th year since…
The first preventative vaccine for HIV was developed at University of Western Ontario
On Dec. 20, 2011, the U.S. Food and Drug Administration (FDA) announced approval of the first and only…
National Women and Girls HIV/AIDS Awareness Day was established
On Mar. 10, 2010, National Women and Girls HIV/AIDS Awareness Day (NWGHAAD) was established as a nationwide initiative…
Thai HIV vaccine clinical trial results were published in the New England Journal of Medicine
On Dec. 3, 2009, the Thai HIV vaccine clinical trial results were published in the New England Journal…
Biotechnology | HIV | Therapeutics | Vaccine
Phase III results for first HIV/AIDS (Aidsvax) vaccine reported
On Sept. 24, 2009, the second Phase III HIV-1 vaccine trial, also known as RV144, that began in…
Francoise Barre-Sinoussi was awarded a share of the Nobel Prize in Physiology or Medicine for the discovery of the human immunodeficiency virus
On Oct. 6, 2008, Francoise Barre-Sinoussi was awarded a share of the 2008 Nobel Prize in Physiology or…
The first HIV case in history was recognized
Jun. 25, 2008, researchers reported that the human immunodeficiency virus (HIV-1) responsible for most of the AIDS cases…
National Cancer Institute symposium showcased HIV/AIDS research
On Oct. 2, 2007, the National Cancer Institute held a symposium to showcase several important historic achievements in…
UCLA launched $20 million stem cell institute to investigate new approaches to HIV, cancer and neurological disorders
On Mar. 16, 2005, University of California, Los Angeles (UCLA) officials announced the formation of the Institute for…
OHSU VGTI received a $3.5 million NIH grant to assist in development of AIDS vaccine
On May 25, 2004, researchers at the Vaccine and Gene Therapy Institute (VGTI) and the Oregon National Primate…
Biotechnology | HIV | Infectious Disease | NIH | Vaccine
$81 million was awarded by NIAID through four new contracts to support development of candidate HIV vaccines
On Sept. 29, 2003, $81 million was awarded by National Institute of Allergy and Infectious Diseases (NIAID) through…
Biotechnology | HIV | Therapeutics | Vaccine
Phase III results for first HIV/AIDS (Aidsvax) vaccine reported
On February 24 2003, VaxGen announced that AIDSVAX B/B did not prove effective in the trials conducted in…
Biotechnology | Disease | HIV | Vaccine
U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) was established
On Jan. 26, 2003, President Bush, in his State of the Union Address, announced the Emergency Plan for…
The CDC reported newborn HIV infection reductions of 80% since 1981
On Jul. 9, 2002, the U.S. Centers for Disease Control and Prevention (CDC) reported newborn HIV infection reductions…
The FDA approved the first nucleic acid test system to screen whole blood donors for infections with HIV and HCV
On Feb. 28, 2002, the FDA announced it had licensed the first nucleic acid test (NAT) system intended…
Biotechnology | Genomics | HIV | Oncology
Stanford researchers became the first to use RNAi to switch off genes in mice
In 2002, Stanford geneticist Mark Kay uses a gene-therapy technique known as RNA inhibition to switch off genes…
Biotechnology | FDA | HIV | Therapeutics
Genentech drug Valcyte (valganciclovir hydrochloride) was approved
On Mar. 29, 2001, the Food and Drug Administration (FDA) announced it had approved Genentech’s drug Valcyte (valganciclovir…
NIAID created global network to advance development of HIV vaccines
On May 25, 2000, the National Institute of Allergy and Infectious Diseases (NIAID) announced funding of nine U.S….